Episode Details

Back to Episodes
Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA

Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA

Published 6 months ago
Description
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘the effectiveness and safety of upadacitinib with secukinumab and adalimumab’ and ‘the efficacy of long-term treatment with risankizumab across the updated GRAPPA domains and key related conditions of PsA’.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us